BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 855 filers reported holding BAXTER INTL INC in Q3 2013. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $85,000 | +7.6% | 985 | 0.0% | 0.01% | -14.3% |
| Q3 2021 | $79,000 | -21.0% | 985 | -20.4% | 0.01% | -12.5% |
| Q2 2021 | $100,000 | -3.8% | 1,238 | 0.0% | 0.01% | -11.1% |
| Q1 2021 | $104,000 | +5.1% | 1,238 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $99,000 | -1.0% | 1,238 | 0.0% | 0.01% | -18.2% |
| Q3 2020 | $100,000 | -6.5% | 1,238 | 0.0% | 0.01% | -15.4% |
| Q2 2020 | $107,000 | +4.9% | 1,238 | -1.6% | 0.01% | -13.3% |
| Q1 2020 | $102,000 | -2.9% | 1,258 | 0.0% | 0.02% | +25.0% |
| Q4 2019 | $105,000 | -4.5% | 1,258 | 0.0% | 0.01% | -14.3% |
| Q3 2019 | $110,000 | +6.8% | 1,258 | 0.0% | 0.01% | +7.7% |
| Q2 2019 | $103,000 | +1.0% | 1,258 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $102,000 | +22.9% | 1,258 | 0.0% | 0.01% | +8.3% |
| Q4 2018 | $83,000 | +1.2% | 1,258 | +18.9% | 0.01% | +9.1% |
| Q3 2018 | $82,000 | +5.1% | 1,058 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $78,000 | -27.8% | 1,058 | -36.2% | 0.01% | -26.7% |
| Q1 2018 | $108,000 | -10.0% | 1,658 | -10.9% | 0.02% | -11.8% |
| Q4 2017 | $120,000 | -2.4% | 1,860 | -5.1% | 0.02% | -5.6% |
| Q3 2017 | $123,000 | +3.4% | 1,959 | 0.0% | 0.02% | 0.0% |
| Q2 2017 | $119,000 | +11.2% | 1,959 | -4.6% | 0.02% | +5.9% |
| Q1 2017 | $107,000 | +40.8% | 2,054 | +20.4% | 0.02% | +30.8% |
| Q4 2016 | $76,000 | -8.4% | 1,706 | -1.7% | 0.01% | -13.3% |
| Q3 2016 | $83,000 | -12.6% | 1,735 | -17.1% | 0.02% | -11.8% |
| Q2 2016 | $95,000 | -22.1% | 2,093 | -29.5% | 0.02% | -19.0% |
| Q1 2016 | $122,000 | -44.0% | 2,970 | -48.0% | 0.02% | -44.7% |
| Q4 2015 | $218,000 | -95.4% | 5,715 | -96.0% | 0.04% | -95.6% |
| Q3 2015 | $4,696,000 | -50.7% | 142,960 | +4.9% | 0.85% | -48.0% |
| Q2 2015 | $9,529,000 | +12.1% | 136,263 | +9.8% | 1.64% | +9.4% |
| Q1 2015 | $8,500,000 | -2.9% | 124,093 | +3.9% | 1.50% | -28.4% |
| Q4 2014 | $8,753,000 | +3.4% | 119,423 | +1.3% | 2.10% | +2.6% |
| Q3 2014 | $8,465,000 | +0.9% | 117,942 | +3.7% | 2.04% | +2.6% |
| Q2 2014 | $8,392,000 | +3.2% | 113,774 | +2.9% | 1.99% | +2.6% |
| Q1 2014 | $8,135,000 | +11.3% | 110,556 | +4.8% | 1.94% | +8.3% |
| Q4 2013 | $7,310,000 | +19.8% | 105,466 | +10.4% | 1.79% | +5.6% |
| Q3 2013 | $6,101,000 | -4.0% | 95,493 | +4.7% | 1.70% | -9.8% |
| Q2 2013 | $6,355,000 | – | 91,219 | – | 1.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |